These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35150156)

  • 21. Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment.
    Resnick SM; Matsumoto AM; Stephens-Shields AJ; Ellenberg SS; Gill TM; Shumaker SA; Pleasants DD; Barrett-Connor E; Bhasin S; Cauley JA; Cella D; Crandall JP; Cunningham GR; Ensrud KE; Farrar JT; Lewis CE; Molitch ME; Pahor M; Swerdloff RS; Cifelli D; Anton S; Basaria S; Diem SJ; Wang C; Hou X; Snyder PJ
    JAMA; 2017 Feb; 317(7):717-727. PubMed ID: 28241356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bipolar Androgen Therapy for Men With Androgen Ablation Naïve Prostate Cancer: Results From the Phase II BATMAN Study.
    Schweizer MT; Wang H; Luber B; Nadal R; Spitz A; Rosen DM; Cao H; Antonarakis ES; Eisenberger MA; Carducci MA; Paller C; Denmeade SR
    Prostate; 2016 Sep; 76(13):1218-26. PubMed ID: 27338150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estradiol for the mitigation of adverse effects of androgen deprivation therapy.
    Russell N; Cheung A; Grossmann M
    Endocr Relat Cancer; 2017 Aug; 24(8):R297-R313. PubMed ID: 28667081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive Impacts of Estrogen Treatment in Androgen-Deprived Males: What Needs to be Resolved.
    Wibowo E
    Curr Neuropharmacol; 2017; 15(7):1043-1055. PubMed ID: 28294068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of androgen deprivation therapy on cognitive functions in patients with metastatic prostate cancer: A multicentric, prospective study of the Society of Urological Surgery Andrology group.
    Cinar O; Turunc T; Kazaz IO; Yildirim O; Deliktas H; Cihan A; Gudeloglu A; Ure I; Deveci S; Sahin B; Cinar BP; Ozkara H
    Int J Clin Pract; 2021 Jun; 75(6):e14095. PubMed ID: 33619782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer.
    Cherrier MM; Aubin S; Higano CS
    Psychooncology; 2009 Mar; 18(3):237-47. PubMed ID: 18636420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of short-term estradiol therapy on cognitive function in older men receiving hormonal suppression therapy for prostate cancer.
    Taxel P; Stevens MC; Trahiotis M; Zimmerman J; Kaplan RF
    J Am Geriatr Soc; 2004 Feb; 52(2):269-73. PubMed ID: 14728639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testosterone Recovery Profiles After Cessation of Androgen Deprivation Therapy for Prostate Cancer.
    Nascimento B; Miranda EP; Jenkins LC; Benfante N; Schofield EA; Mulhall JP
    J Sex Med; 2019 Jun; 16(6):872-879. PubMed ID: 31080102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgens and prostate cancer; pathogenesis and deprivation therapy.
    Grossmann M; Cheung AS; Zajac JD
    Best Pract Res Clin Endocrinol Metab; 2013 Aug; 27(4):603-16. PubMed ID: 24054933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.
    McGinty HL; Phillips KM; Jim HS; Cessna JM; Asvat Y; Cases MG; Small BJ; Jacobsen PB
    Support Care Cancer; 2014 Aug; 22(8):2271-80. PubMed ID: 24859915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of long-term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer.
    Alibhai SM; Timilshina N; Duff-Canning S; Breunis H; Tannock IF; Naglie G; Fleshner NE; Krahn MD; Warde P; Marzouk S; Tomlinson GA
    Cancer; 2017 Jan; 123(2):237-244. PubMed ID: 27583806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer treatment and the relationship of androgen deprivation therapy to cognitive function.
    Reiss AB; Saeedullah U; Grossfeld DJ; Glass AD; Pinkhasov A; Katz AE
    Clin Transl Oncol; 2022 May; 24(5):733-741. PubMed ID: 34743290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503).
    Morris MJ; Mota JM; Lacuna K; Hilden P; Gleave M; Carducci MA; Saad F; Cohn ED; Filipenko J; Heller G; Shore N; Armstrong AJ; Scher HI
    Eur Urol Oncol; 2021 Aug; 4(4):543-552. PubMed ID: 34020931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differing Effects of Zoledronic Acid on Bone Microarchitecture and Bone Mineral Density in Men Receiving Androgen Deprivation Therapy: A Randomized Controlled Trial.
    Cheung AS; Hoermann R; Ghasem-Zadeh A; Tinson AJ; Ly V; Milevski SV; Joon DL; Zajac JD; Seeman E; Grossmann M
    J Bone Miner Res; 2020 Oct; 35(10):1871-1880. PubMed ID: 32542695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomechanical Leg Muscle Function During Stair Ambulation in Men Receiving Androgen Deprivation Therapy.
    Cheung AS; Gray HA; Schache AG; Hoermann R; Bicknell J; Joon DL; Zajac JD; Pandy MG; Grossmann M
    J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(9):1715-1722. PubMed ID: 31310271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive changes associated with ADT: a review of the literature.
    Jamadar RJ; Winters MJ; Maki PM
    Asian J Androl; 2012 Mar; 14(2):232-8. PubMed ID: 22343495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships between insulin resistance and frailty with body composition and testosterone in men undergoing androgen deprivation therapy for prostate cancer.
    Cheung AS; Hoermann R; Dupuis P; Joon DL; Zajac JD; Grossmann M
    Eur J Endocrinol; 2016 Sep; 175(3):229-37. PubMed ID: 27340081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symptomatic response to testosterone treatment in dieting obese men with low testosterone levels in a randomized, placebo-controlled clinical trial.
    Ng Tang Fui M; Hoermann R; Prendergast LA; Zajac JD; Grossmann M
    Int J Obes (Lond); 2017 Mar; 41(3):420-426. PubMed ID: 28028318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of long-term testosterone administration on cognition in older men with low or low-to-normal testosterone concentrations: a prespecified secondary analysis of data from the randomised, double-blind, placebo-controlled TEAAM trial.
    Huang G; Wharton W; Bhasin S; Harman SM; Pencina KM; Tsitouras P; Li Z; Hally KA; Asthana S; Storer TW; Basaria S
    Lancet Diabetes Endocrinol; 2016 Aug; 4(8):657-665. PubMed ID: 27377542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical function in men with prostate cancer on androgen deprivation therapy.
    Clay CA; Perera S; Wagner JM; Miller ME; Nelson JB; Greenspan SL
    Phys Ther; 2007 Oct; 87(10):1325-33. PubMed ID: 17684084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.